Common Names
Sassafras
How this plant is used
Medicinal
Chemical Name | Activity Count | Plant Part | Low Parts Per Million | High Parts Per Million | Standard Deviation | Reference |
---|---|---|---|---|---|---|
(E)-BETA-OCIMENE | 0 | Leaf | 9.4 | 21.0 | 0.25 | Duke, 1992 * |
(E,Z)-ALPHA-FARNESENE | 0 | Leaf | 14.0 | 15.0 | not available | Duke, 1992 * |
(Z)-BETA-OCIMENE | 0 | Leaf | 2.6 | 8.0 | -0.70 | Duke, 1992 * |
(Z)-NEROLIDOL | 0 | Leaf | 40.0 | 85.0 | not available | Duke, 1992 * |
1,6-GERMACRADIEN-5-OL | 0 | Leaf | 0.2 | 10.0 | not available | Duke, 1992 * |
1,8-CINEOLE | 67 | Leaf | 0.0 | 1.6 | -0.53 | Duke, 1992 * |
4-ALLYL-1,2-(METHYLENEDIOXY)-BENZENE | 0 | Plant | not available | not available | not available | J.S. Glasby Dict.Pls Containing 2ndary Metabolite. 1991. |
5-METHOXYEUGENOL | 0 | Root | not available | not available | not available | CRC Handbook of Medicinal Herbs and/or CRC Handbook of Proximate Analyses |
6-METHYL-5-HEPTEN-2-ONE | 0 | Leaf | not available | 0.0 | -1.00 | Duke, 1992 * |
ALKALOIDS | 0 | Root | not available | 200.0 | -0.91 | Duke, 1992 * |
ALLO-AROMADENDRENE | 0 | Leaf | not available | 0.0 | -0.20 | Duke, 1992 * |
ALPHA-COPAENE | 0 | Leaf | not available | 0.0 | -0.36 | Duke, 1992 * |
ALPHA-HUMULENE | 2 | Leaf | 0.0 | 8.4 | -0.45 | Duke, 1992 * |
ALPHA-PHELLANDRENE | 11 | Leaf | 1.0 | 6.1 | -0.31 | Duke, 1992 * |
ALPHA-PHELLANDRENE | 11 | Root | not available | not available | not available | Leung, A. Y. and Foster, S. 1995. Encyclopedia of Common Natural Ingredients 2nd Ed. John Wiley & Sons, New York. 649 pp. |
ALPHA-PINENE | 28 | Leaf | 0.1 | 5.0 | -0.22 | Duke, 1992 * |
ALPHA-PINENE | 28 | Root | 1000.0 | 2000.0 | 0.22 | List, P.H. and Horhammer, L., Hager's Handbuch der Pharmazeutischen Praxis, Vols. 2-6, Springer-Verlag, Berlin, 1969-1979. |
ALPHA-SELINENE | 3 | Leaf | 0.0 | 8.9 | -0.62 | Duke, 1992 * |
ALPHA-TERPINENE | 13 | Leaf | not available | 0.0 | -0.31 | Duke, 1992 * |
ALUMINUM | 5 | Leaf | 50.0 | 1360.0 | 0.68 | Duke, 1992 * |
Activity | Chemical Count | Reference |
---|---|---|
(-)-Chronotropic | 1 | Hansel, R., Keller, K., Rimpler, H., and Schneider, G. eds. 1992. Hager's Handbuch der Pharmazeutischen Praxis, Drogen (A-D), 1209 pp., 1993 (E-O), 970 pp., 1994 (P-Z), 1196 pp. Springer-Verlag, Berlin. |
(-)-Inotropic | 1 | Hansel, R., Keller, K., Rimpler, H., and Schneider, G. eds. 1992. Hager's Handbuch der Pharmazeutischen Praxis, Drogen (A-D), 1209 pp., 1993 (E-O), 970 pp., 1994 (P-Z), 1196 pp. Springer-Verlag, Berlin. |
5-Alpha-Reductase-Inhibitor | 2 | Duke, 1992 * |
Abortifacient | 3 | Duke, 1992 * |
Absorbent | 1 | Martindale's 29th |
Acaricide | 6 | Duke, 1992 * |
ACE-Inhibitor | 4 | Duke, 1992 * |
AChE-Inhibitor | 1 | Grundy, D. L. and Still, C. C., Inhibition of acetylcholinesterases by pulegone-1,2-epoxide, Oest. Biochem. & Physiol., 23, 1985, 383-8. |
Aldose-Reductase-Inhibitor | 5 | Duke, 1992 * |
Allelochemic | 3 | Duke, 1992 * |
Allelopathic | 4 | Duke, 1992 * |
Allergenic | 11 | Duke, 1992 * |
Alpha-Reductase-Inhibitor | 1 | Duke, 1992 * |
Amphetaminagenic | 1 | Duke, 1992 * |
Amphiglycemic? | 1 | Davies, S., and Stewart, A. 1990. Nutritional Medicine. Avon Books, New York. 509pp. |
Analgesic | 8 | Duke, 1992 * |
Androgenic | 2 | Duke, 1992 * |
Anemiagenic | 1 | Duke, 1992 * |
Anesthetic | 6 | Duke, 1992 * |
Angiogenic | 1 | Duke, 1992 * |